Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.

PubWeight™: 5.01‹?› | Rank: Top 1%

🔗 View Article (PMC 64791)

Published in BMJ on January 26, 2002

Authors

Sander Koning1, Lisette W A van Suijlekom-Smit, Jan L Nouwen, Cees M Verduin, Roos M D Bernsen, Arnold P Oranje, Siep Thomas, Johannes C van der Wouden

Author Affiliations

1: Department of General Practice, University Hospital Rotterdam, Room Ff325, PO Box 1738, Erasmus University, 3000 DR Rotterdam, Netherlands.

Articles citing this

Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest (2004) 2.86

Improving health care globally: a critical review of the necessity of family medicine research and recommendations to build research capacity. Ann Fam Med (2004) 2.71

Clustering by health professional in individually randomised trials. BMJ (2005) 1.85

A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract (2003) 1.57

Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child (2004) 1.32

Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol (2003) 1.15

Fusidic acid cream for impetigo. Fusidic acid should be used with restraint. BMJ (2002) 1.05

Fusidic acid cream for impetigo. Findings cannot be extrapolated. BMJ (2002) 0.96

Fusidic acid cream for impetigo. Problem may be clinically important. BMJ (2002) 0.95

Research in family/general practice is essential for improving health globally. Ann Fam Med (2004) 0.90

Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use. BMJ (2002) 0.87

Fusidic acid cream for impetigo. Judicious use is advisable. BMJ (2002) 0.83

Staphylococcus aureus carriage among GPs in The Netherlands. Br J Gen Pract (2010) 0.81

Fusidic acid cream for impetigo. Resistance trends must be monitored. BMJ (2002) 0.81

Modelling of the outcome of non-inferiority trials by integration of historical data. J Pharmacokinet Pharmacodyn (2011) 0.75

Articles cited by this

Fucidin: a new orally active antibiotic. Lancet (1962) 3.25

Comparison of mupirocin and erythromycin in the treatment of impetigo. J Pediatr (1990) 2.39

Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995. J Antimicrob Chemother (1998) 2.33

Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother (1997) 2.17

Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol (1999) 2.04

Resistance to antibiotics used in dermatological practice. Br J Dermatol (1998) 1.30

Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol (1989) 1.28

Experimental infection of the skin in the hamster simulating human impetigo. II. Assessment of various therapeutic regimens. Pediatrics (1971) 1.25

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother (1992) 1.22

Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J (1997) 1.22

A three-year study of impetigo in Sydney. Med J Aust (1987) 1.20

The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo. Pediatrics (1973) 1.17

Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol (1989) 1.14

Prescribing antibiotics for impetigo. Drugs (1988) 1.12

A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin (1988) 1.12

Treatment of impetigo: a review. Pediatr Infect Dis (1985) 1.09

Articles by these authors

The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80

Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis (2008) 7.45

Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis (2009) 2.79

What is the clinical course of acute ankle sprains? A systematic literature review. Am J Med (2008) 2.26

Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child (2007) 2.19

Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother (2005) 2.18

Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis (2009) 2.03

The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum (2008) 1.89

Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med (2003) 1.81

Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA (2011) 1.80

Treatment for impetigo. BMJ (2004) 1.66

Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics. Br J Gen Pract (2005) 1.58

Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol (2011) 1.55

Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. Ann Rheum Dis (2007) 1.55

Difference between parental perception and actual weight status of children: a systematic review. Matern Child Nutr (2012) 1.52

Diagnosis of lumbar spinal stenosis: a systematic review of the accuracy of diagnostic tests. Spine (Phila Pa 1976) (2006) 1.47

Duration of fever and course of symptoms in young febrile children presenting with uncomplicated illness. J Am Board Fam Med (2013) 1.45

Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis (2006) 1.45

Exhaled nitric oxide measures allergy not symptoms in children with allergic rhinitis in primary care: a prospective cross-sectional and longitudinal cohort study. Prim Care Respir J (2013) 1.44

Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother (2004) 1.44

Process evaluation of a multifaceted intervention to improve cardiovascular disease prevention in general practice. Eur J Gen Pract (2003) 1.43

Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther (2002) 1.41

Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns (2004) 1.40

The effect of educational intervention on intercultural communication: results of a randomised controlled trial. Br J Gen Pract (2005) 1.39

Influenza vaccination in healthy children. Vaccine (2006) 1.38

Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men. Eur Urol (2006) 1.38

Improving quality of organizing cardiovascular preventive care in general practice by outreach visitors: a randomized controlled trial. Prev Med (2002) 1.35

Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother (2005) 1.27

Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus. J Clin Microbiol (2006) 1.27

Trends in prescribing antibiotics for children in Dutch general practice. J Antimicrob Chemother (2004) 1.26

Lack of uniformity in diagnostic labeling of shoulder pain: time for a different approach. Man Ther (2008) 1.25

Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology (2004) 1.24

Mastocytosis in children: a protocol for management. Pediatr Dermatol (2008) 1.20

Organizing cardiovascular preventive care in general practice: determinants of a successful intervention. Prev Med (2002) 1.19

Interventions for impetigo. Cochrane Database Syst Rev (2012) 1.19

Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial. Cancer (2006) 1.18

The natural course of chronic benign pain in childhood and adolescence: a two-year population-based follow-up study. Eur J Pain (2003) 1.17

Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res (2008) 1.16

Oral lichen planus in childhood. Pediatr Dermatol (2005) 1.16

Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol (2003) 1.15

Diagnosis and management of juvenile idiopathic arthritis. BMJ (2010) 1.14

Triage of febrile children at a GP cooperative: determinants of a consultation. Br J Gen Pract (2008) 1.12

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev (2014) 1.11

Analysis of under- and overprescribing of antibiotics in acute otitis media in general practice. J Antimicrob Chemother (2005) 1.09

Increasing incidence of skin disorders in children? A comparison between 1987 and 2001. BMC Dermatol (2006) 1.08

Psychosocial factors associated with chronic pain in adolescents. Pain (2003) 1.08

Changing morbidity patterns in children in Dutch general practice: 1987-2001. Eur J Gen Pract (2005) 1.07

Do Dutch doctors communicate differently with immigrant patients than with Dutch patients? Soc Sci Med (2006) 1.06

Normal values and determinants of circadian urine production in older men: a population based study. J Urol (2002) 1.04

Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol (2007) 1.04

Primary prevention of overweight in children and adolescents: a meta-analysis of the effectiveness of interventions aiming to decrease sedentary behaviour. Int J Behav Nutr Phys Act (2012) 1.03

Musculoskeletal problems in overweight and obese children. Ann Fam Med (2009) 1.02

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol (2008) 1.01

Birth order and sibship size as independent risk factors for asthma, allergy, and eczema. Pediatr Allergy Immunol (2003) 1.00

Epidemiology of unintentional injuries in childhood: a population-based survey in general practice. Br J Gen Pract (2005) 1.00

Incidence of influenza and associated illness in children aged 0-19 years: a systematic review. Rev Med Virol (2005) 0.98

Provision of information and advice in cardiovascular care: clinical performance of general practitioners. Patient Educ Couns (2002) 0.98

Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. Arthritis Rheum (2003) 0.97

Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Pediatr Blood Cancer (2010) 0.97

Childhood nonspecific abdominal pain in family practice: incidence, associated factors, and management. Ann Fam Med (2011) 0.96

Refractive errors and visual impairment in 900 adults with intellectual disabilities in the Netherlands. Acta Ophthalmol Scand (2003) 0.95

Factors related to the quality of life in adolescents with chronic pain. Clin J Pain (2006) 0.95

A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin. Eur J Pediatr (2003) 0.94

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010. J Rheumatol (2011) 0.94

Physically unexplained chronic pain and its impact on children and their families: the mother's perception. Psychol Psychother (2002) 0.93

Long-term followup of temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Rheum (2008) 0.93

Feasibility of diabetes peer education for Turkish type 2 diabetes patients in Dutch general practice. Patient Educ Couns (2004) 0.92

Stability of pain parameters and pain-related quality of life in adolescents with persistent pain: a three-year follow-up. Clin J Pain (2002) 0.92

MRI follow-up of posttraumatic bone bruises of the knee in general practice. AJR Am J Roentgenol (2007) 0.91

Incidence rates and management of urinary tract infections among children in Dutch general practice: results from a nation-wide registration study. BMC Pediatr (2006) 0.91

Attitude, knowledge and behaviour towards evidence-based medicine of physical therapists, students, teachers and supervisors in the Netherlands: a survey. J Eval Clin Pract (2011) 0.91

Body mass index, sexual behaviour, and sexually transmitted infections: an analysis using the NHANES 1999-2000 data. BMC Public Health (2006) 0.91

Kinesiophobia in patients with non-traumatic arm, neck and shoulder complaints: a prospective cohort study in general practice. BMC Musculoskelet Disord (2007) 0.91

Vitamin D supplementation for nonspecific musculoskeletal pain in non-Western immigrants: a randomized controlled trial. Ann Fam Med (2012) 0.90

Acute non-traumatic hip pathology in children: incidence and presentation in family practice. Fam Pract (2009) 0.90

Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis. Dermatology (2007) 0.90

Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. J Invest Dermatol (2007) 0.89

Foot problems in children presented to the family physician: a comparison between 1987 and 2001. Fam Pract (2009) 0.88

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study. PLoS One (2013) 0.88

A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species. Plasmid (2004) 0.88